Hematology

Welcome to your home for all things Mayo Clinic Hematology. At Mayo Clinic, hematologists work in collaboration with teams of experts from virtually every medical and surgical specialty for the care of adults and children with blood diseases, including various cancers of the blood and bone marrow.

Follow the Hematology page and stay up-to-date as we post stories, clinical trials, resources, and useful information regarding your hematological diagnosis. Post a comment and share your thoughts.

PUBLIC PAGE
Feb 17, 2020

CLL: Mayo Clinic's approach to diagnosis

By Justin McClanahan @JustinMcClanahan
Approximately 20,000 patients will be diagnosed with chronic lymphocytic leukemia (CLL) in the United States alone in 2019. Many of these patients will be in the early-stage of their disease at the time of their diagnosis and will not meet indications for therapy (learn more about this period known [...]
CLL: Mayo Clinic's approach to diagnosis
Feb 4, 2020

World Cancer Day 2020

By Justin McClanahan @JustinMcClanahan
February 4th is an international day dedicated to raising awareness about cancer and cancer research. At Mayo Clinic, the Mayo Clinic Cancer Center defines new boundaries in possibility, focusing on patient-centered care, developing novel treatments, training future generations of cancer experts, and bringing cancer research to communities. Mayo [...]
World Cancer Day 2020
Jan 20, 2020

Chronic Lymphocytic Leukemia: Changes in frontline treatment

By Justin McClanahan @JustinMcClanahan
Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The term "chronic" in chronic lymphocytic leukemia comes from the fact that it typically progresses more slowly than other types of leukemia. [...]
Chronic Lymphocytic Leukemia: Changes in frontline treatment
Jan 6, 2020

CLL: What is 'watch & wait' and what can a patient do during this phase?

By Justin McClanahan @JustinMcClanahan
Many newly diagnosed chronic lymphocytic leukemia (CLL) patients are in the early-stage and do not meet the typical criteria to begin treatment. This may go against what is commonly known to many in that, typically, catching cancers early and beginning treatment immediately achieves the best possible outcome. "This [...]
CLL: What is 'watch & wait' and what can a patient do during this phase?
Dec 17, 2019

Multiple Myeloma: Smoldering, disease progression, and changes in approach

By Justin McClanahan @JustinMcClanahan
All patients with multiple myeloma start with a diagnosis of monoclonal gammopathy of unknown significance (MGUS). But, how concerned should a patient be when receiving a MGUS diagnosis? While some patients do go on to develop multiple [...]
Multiple Myeloma: Smoldering, disease progression, and changes in approach

Invite Others

Send an email to invite people you know to join the Hematology page.

Please login or register to send an invite.